The Complete Guide to Magnesium Forms: 8 Types Compared by Bioavailability, Use Case, and Evidence

When you read "400mg Magnesium" on a supplement label, that number tells you almost nothing about how much magnesium your body will actually absorb. What determines absorbed magnesium is not the label dose — it is the elemental magnesium content of the specific salt form combined with that form's gastrointestinal absorption rate. These two numbers multiply together, and the product varies enormously across common forms.

Magnesium oxide illustrates the problem clearly. Oxide is the most prevalent form in the supplement market because it is inexpensive to manufacture and packs the highest elemental magnesium content of any common form at approximately 60%. A capsule containing 400mg of magnesium oxide contains roughly 240mg of elemental magnesium. But magnesium oxide has a gastrointestinal absorption rate of approximately 4% — meaning only about 9-10mg of that elemental magnesium actually crosses the intestinal wall into systemic circulation. The rest acts as an osmotic laxative, drawing water into the colon.

Magnesium glycinate (bisglycinate) presents the opposite profile. Its elemental magnesium content is approximately 14%, which means a 400mg dose contains only about 56mg of elemental magnesium. However, glycinate's amino acid chelation pathway yields an absorption rate of approximately 24%, delivering around 13-14mg of absorbed magnesium — more than oxide at a fraction of the elemental content. The chelation to glycine bypasses the saturable intestinal transport channels that limit inorganic magnesium salts.

This gap between label dose and absorbed dose is the core consumer education problem in the magnesium market, and it is why form selection matters more than chasing the highest milligram number on the front of a bottle.

Magnesium glycinate — also sold as magnesium bisglycinate, reflecting that two glycine molecules chelate each magnesium ion — is consistently rated the preferred general-purpose form by nutrition researchers and practitioners for a combination of reasons: absorption quality, tolerability, and synergistic effects from the glycine co-molecule.

Glycine is a non-essential amino acid with well-documented calming effects in the central nervous system. It functions as an inhibitory neurotransmitter in the brainstem and spinal cord and has been studied for its contribution to sleep quality and relaxation independent of its magnesium carrier function. The glycine component of magnesium glycinate may contribute meaningfully to the sleep-supporting effects this form is known for — effects that other magnesium forms with equivalent elemental magnesium content do not produce with the same consistency.

From a tolerance standpoint, magnesium glycinate produces minimal laxative effect at standard supplemental doses compared to oxide, citrate, or sulfate. The chelation chemistry means the magnesium is absorbed through amino acid transport pathways rather than depending on the passive paracellular diffusion that inorganic salts rely on at lower luminal concentrations. This reduces the osmotic load in the colon and the associated looser stools that discourage compliance with other forms.

FormulaForge classifies magnesium glycinate as the T1 (tier 1, preferred form) within the magnesium ingredient family. It is the default form we use in personalized formulations when a customer's health goals center on sleep quality, stress resilience, muscle relaxation, or general magnesium repletion.

Typical effective dose: 200-400mg elemental magnesium daily, which corresponds to approximately 1,400-2,800mg of magnesium bisglycinate by weight. The broad range reflects individual variation in dietary magnesium intake and absorption capacity. Split dosing across morning and evening is well-tolerated and may improve total daily absorption by avoiding saturation of the amino acid transport channels.

Magnesium L-threonate occupies a distinct position in the magnesium landscape: it is the only form that has been specifically demonstrated in preclinical research to increase magnesium concentrations in cerebrospinal fluid after oral supplementation. This property reflects the threonate molecule's apparent ability to facilitate magnesium transport across the blood-brain barrier — a physiological boundary that other magnesium forms do not appear to cross in meaningful quantities.

The form was developed at MIT by researchers studying magnesium's role in synaptic density and cognitive function. The commercial version, sold under the trade name Magtein, has been studied in human trials examining working memory, attention, and age-related cognitive changes. Preclinical data showing increased brain magnesium concentrations and improved synaptic plasticity initiated clinical interest; human trials have shown modest but measurable improvements in cognitive composite scores in older adults.

There is an important trade-off with L-threonate: it delivers substantially less elemental magnesium per capsule than glycinate or citrate. A standard clinical dose of 2,000mg of magnesium L-threonate contains only approximately 144mg of elemental magnesium. Individuals using threonate as their sole magnesium supplement may need to supplement with a higher-elemental form or focus heavily on dietary magnesium to meet total daily requirements.

The ideal use case for L-threonate is therefore not general magnesium repletion — it is targeted support for cognitive function and brain magnesium status, ideally alongside a higher-elemental form covering total body magnesium needs. The cost per serving is meaningfully higher than glycinate or citrate, which warrants consideration when evaluating whether the additional investment aligns with a customer's specific health goals.

FormulaForge does not make claims about magnesium L-threonate treating any neurological condition. The above reflects structure/function observations from published research, not therapeutic claims.

Magnesium citrate is the most widely available well-absorbed form and serves as the reasonable default choice for individuals who want meaningful magnesium absorption at a lower cost than glycinate or threonate. Its bioavailability is estimated at approximately 16% — meaningfully higher than oxide and sufficient for effective supplementation in most healthy adults.

The citric acid component of this form contributes mild laxative activity at higher doses. This is dose-dependent: at 200-300mg elemental magnesium daily, most individuals experience no laxative effect, but doses above 350-400mg elemental are associated with looser stools in a subset of users. This effect is exploited intentionally in over-the-counter laxative products that use magnesium citrate at higher doses, but it can be a compliance barrier when the goal is supplementation rather than bowel preparation.

Compared to glycinate, magnesium citrate lacks the glycine co-molecule and its associated calming and sleep-modulating effects. For individuals whose primary goal is sleep quality or stress resilience, this is a meaningful functional gap. For individuals whose primary goal is general magnesium intake at moderate cost, citrate is a pragmatic choice.

Magnesium citrate is well-suited for: general daily supplementation, individuals with normal magnesium absorption, and anyone seeking a balance between cost and absorption quality. It is the starting-point recommendation when budget is a constraint and cognitive or sleep-specific effects are not the primary driver.

Typical dose: 200-400mg elemental magnesium daily, corresponding to approximately 1,700-3,400mg of magnesium citrate by weight. Starting at the lower end and titrating upward based on stool consistency is the standard approach.

Magnesium oxide is the dominant form in the global magnesium supplement market by unit volume, and the reason is straightforward: it is the cheapest form to manufacture. Its high elemental magnesium content (approximately 60%) means manufacturers can put a large milligram number on the label at minimal raw material cost, which translates to competitive retail pricing and attractive label claims.

The problem is absorption. Magnesium oxide is an inorganic salt with low aqueous solubility. In the gastrointestinal tract, it depends primarily on passive diffusion for absorption, which is the least efficient magnesium uptake pathway. Published studies measuring gastrointestinal absorption via stable isotope methods have found magnesium oxide absorption rates of approximately 4% — substantially below the 16-24% range observed for organic salt forms like citrate and glycinate.

The practical arithmetic is stark. A supplement labeled "400mg Magnesium" from magnesium oxide delivers approximately 240mg of elemental magnesium, of which roughly 9-10mg is absorbed. A supplement labeled "200mg Magnesium" from magnesium glycinate delivers approximately 28mg of elemental magnesium (from a standard dose of the chelate), of which approximately 7mg is absorbed — a comparable systemic delivery from a dramatically lower label dose, at a comparable or lower cost per unit of absorbed magnesium.

At supplemental doses, the unabsorbed magnesium oxide acts as an osmotic agent, drawing water into the large intestine and producing the laxative effect that gives magnesium oxide its only legitimate supplemental use case: occasional constipation relief. For individuals purchasing a magnesium supplement to support sleep, muscle function, stress, or cardiovascular health, magnesium oxide is a poor form choice regardless of its low price or high label dose.

This is the form FormulaForge exists to replace. When a patient's supplement label includes magnesium oxide, it is typically the first candidate for form upgrade in a personalized formulation.

Beyond the high-volume forms, three specialized magnesium salts address specific physiological goals. None has the research depth of glycinate or citrate, but each has a plausible mechanism and an appropriate use case.

Magnesium malate pairs magnesium with malic acid, an intermediate in the Krebs cycle (citric acid cycle) involved in cellular energy production. Because malic acid is also used in the metabolic pathway that reduces excess lactic acid, magnesium malate has been studied in the context of muscle fatigue, fibromyalgia-related muscle discomfort, and energy support. Individuals who notice muscle soreness or fatigue as a primary complaint may prefer malate for the theoretical synergy between the two components. Bioavailability is moderate and comparable to citrate; head-to-head absorption studies against glycinate are limited.

Magnesium taurate combines magnesium with the amino acid taurine. Taurine independently has been studied for cardiovascular function, including blood pressure regulation and cardiac muscle stability. Some practitioners favor magnesium taurate specifically for cardiovascular support goals, reasoning that the taurine contribution adds a second mechanism beyond magnesium's direct role in vascular smooth muscle relaxation. Research on the combination specifically is limited; most evidence supports taurine and magnesium independently rather than the chelated form.

Magnesium orotate uses orotic acid — an intermediate in pyrimidine nucleotide synthesis — as the chelating molecule. It has been studied in the context of exercise performance and cardiac function, with some older European trials examining it in patients with heart failure as an adjunct to standard care. Modern clinical data on magnesium orotate is limited, and it tends to be significantly more expensive than other forms. Its appropriate use case is narrow: individuals specifically interested in the orotic acid co-molecule, typically for exercise performance or cardiac support, under practitioner supervision.

All three forms are acceptable alternatives to glycinate when their specific co-molecule provides additional rationale for the individual's health goals. They are not superior general-purpose magnesium supplements.

Topical magnesium application — in the form of Epsom salt baths (magnesium sulfate) or magnesium chloride oil and lotions — is a popular wellness practice. The theoretical basis is transdermal absorption: if magnesium can penetrate the skin in meaningful quantities, topical application would provide systemic magnesium without any gastrointestinal considerations. The practical evidence for this pathway is considerably more limited than the marketing around these products suggests.

Magnesium sulfate (Epsom salt) is the most commonly used topical form. Published studies examining whether Epsom salt baths measurably raise serum or urine magnesium levels have produced inconsistent results. Some small studies have found modest increases in serum magnesium after prolonged hot-water baths; others have found no significant change. The relaxation benefits associated with Epsom salt baths are well-documented subjectively, but they may derive from the hot water and parasympathetic activation of a bath rather than from magnesium absorption specifically.

Magnesium chloride applied topically as oil or lotion is marketed specifically for transdermal delivery. Some small studies examining muscle cramp relief with topical chloride have shown promising results, but the mechanism is not clearly established as systemic magnesium elevation. Local effects on muscle tissue near the application site, and the massage component of application, may contribute to the reported benefits independently of any systemic absorption.

The evidence-based conclusion is: topical magnesium products should not be relied upon as the primary strategy for correcting magnesium insufficiency or achieving systemic supplementation goals. If topical application provides comfort or relaxation benefits for an individual, there is no safety concern with its use. It should simply be understood as supplementary rather than equivalent to oral magnesium in terms of systemic delivery.

Choosing the right magnesium form requires matching the form's absorption pathway and co-molecule properties to the individual's primary health goal. The following framework reflects the current state of evidence and FormulaForge's formulation approach:

Sleep quality and stress resilience: Magnesium glycinate is the first-line recommendation. The glycine component contributes calming effects independent of the magnesium itself, and the form's superior tolerability supports consistent nightly dosing without GI disruption.

Cognitive function and brain magnesium: Magnesium L-threonate is the appropriate form. Its apparent blood-brain barrier penetration makes it uniquely suited to brain-targeted supplementation. Pair with glycinate or citrate to cover total body magnesium needs, since threonate delivers limited elemental magnesium per dose.

General daily supplementation: Magnesium glycinate or citrate are both appropriate. Glycinate is preferred for tolerance and sleep support; citrate is the pragmatic choice when cost is a constraint and GI tolerance is not a concern.

Muscle function and physical performance: Magnesium glycinate or malate. Malate's malic acid component offers theoretical synergy with Krebs cycle energy production and lactate clearance. Glycinate is preferred when sleep quality is also a goal.

Cardiovascular support: Magnesium taurate, leveraging taurine's independently studied cardiovascular properties. Practitioner guidance is appropriate when cardiovascular goals are the primary driver.

Constipation relief: Magnesium oxide or citrate at higher doses. This is one context where oxide's osmotic laxative activity is the feature, not the bug. Use under the guidance of a healthcare provider.

Forms to avoid for general supplementation: Magnesium oxide (poor absorption), topical forms (insufficient evidence for systemic delivery).

Dosing guidance: The RDA for magnesium is 310-420mg per day for adults, depending on age and sex. Most dietary surveys indicate a majority of adults fall below this through diet alone. Supplemental doses of 200-400mg elemental magnesium daily cover the gap for most individuals. Split doses taken with meals — morning and evening — tend to be better tolerated and may improve total absorption by preventing saturation of intestinal transport.

Important: Individuals with kidney disease, heart conditions, or those taking medications that affect magnesium levels should consult their healthcare provider before supplementing. FormulaForge supplements are not intended to diagnose, treat, cure, or prevent any disease.